Comparison of CHA2DS2-VA and CHA2DS2-VASc scores for predicting residual risk of stroke and adverse outcomes in anticoagulated patients with atrial fibrillation: a report from a European registry
30 March 2025 (08:00 - 15:30)
Organised by: 

About the speaker

Modena Polyclinic Modena University Hospital, Modena (Italy)
5 More presentations in this session

Mr J. Rodriguez Garcia (Hospitalet De Llobregat, ES)
Miss C. Van Deutekom (Groningen, NL)
Access the full session
The Event
EHRA 2025
30 March - 1 April 2025




